New medicine for house dust mite allergic rhinitis now available in Japan
November 25, 2015 20:00 ET
|
ALK Abello
Copenhagen, 2015-11-26 02:00 CET (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the sublingual allergy immunotherapy product MITICURE™ now will be...
ALK to present at Jefferies Autumn 2015 Global Healthcare Conference in London
November 06, 2015 06:15 ET
|
ALK Abello
Copenhagen, 2015-11-06 12:15 CET (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the Company will present at the Jefferies Autumn 2015 Global Healthcare...
BioCryst Reports Third Quarter 2015 Financial Results
November 05, 2015 06:55 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the third quarter ended September 30, 2015.
"The...
ALK’s partner, Torii, obtains approval for the house dust mite SLIT-tablet in Japan
September 28, 2015 03:00 ET
|
ALK Abello
Copenhagen, 2015-09-28 09:00 CEST (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Approval releases milestone payment to ALK. ALK now expects operating profit (EBITDA before...
ALKs partner, Torii, opnår godkendelse af tabletvaccine mod husstøvmideallergi i Japan
September 28, 2015 03:00 ET
|
ALK Abello
København, 2015-09-28 09:00 CEST (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Godkendelsen udløser en milepælsbetaling til ALK. ALK forventer nu et primært driftsresultat...
ALK opnår europæisk godkendelse af tabletvaccinen mod husstøvmide-allergi for både allergisk rhinitis og allergisk astma
August 31, 2015 06:50 ET
|
ALK Abello
København, 2015-08-31 12:50 CEST (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) afholder i dag kl. 14.00 (CEST) en telefonkonference for investorer og analytikere, hvor...
ALK obtains European approval for its house dust mite sublingual allergy immunotherapy tablet against allergic rhinitis and allergic asthma
August 31, 2015 06:50 ET
|
ALK Abello
Copenhagen, 2015-08-31 12:50 CEST (GLOBE NEWSWIRE) --
Today at 2.00 p.m. (CEST), ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) will host a conference call for analysts and investors...
ALK to participate at the Goldman Sachs Biotech and Emerging Pharma Symposium in London
August 20, 2015 04:48 ET
|
ALK Abello
Copenhagen, 2015-08-20 10:48 CEST (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the Company will be hosting investor meetings during the Goldman Sachs...
ALK to present at the Morgan Stanley Global Healthcare Conference in New York
August 19, 2015 08:24 ET
|
ALK Abello
Copenhagen, 2015-08-19 14:24 CEST (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the Company will present at the Morgan Stanley Global Healthcare...
Six-month interim report (Q2) 2015 for ALK
August 18, 2015 02:00 ET
|
ALK Abello
Copenhagen, 2015-08-18 08:00 CEST (GLOBE NEWSWIRE) --
Performance for the period (unaudited)
(Comparative figures for 2014 are shown in brackets / revenue growth is measured in local...